Cystic Fibrosis INSP Related Carrier Screen | Back to Test Directory | ||||
Test Description |
|
||||
Screening for up to 23 cystic fibrosis mutations offered to individuals whose family member was identified by the state's Newborn Screening Program. | |||||
Panel Components | |||||
Cystic Fibrosis INSP Related Carrier Screen | |||||
Performed | Avg. Turnaround Time | Method | |||
Ankeny 24/7 |
5 - 10 business days | Nucleic Acid Amplification by Polymerase Chain Reaction (PCR) | |||
Fee | CPT Code(s) | ||||
$106.53 | 81220 | ||||
Specimen Requirements | |||||
Specimen Type: | Blood spot specimen (preferred) or Blood specimen | ||||
Collection Instructions: |
Blood spot specimen (preferred): Use a Whatman 903 Filter Paper Card to collect a specimen from a finger. Refer to the Clinical and Laboratory Standards Institute document GP42-A6, Procedures and Devices for the Collection of Diagnostic Capillary Blood Specimens; Approved Standard-Sixth Edition. Allow blood specimen to air dry at room temperature in a horizontal position for at least three hours. |
||||
Temperature and Stability: | Blood spot specimen: Room Temperature. Blood specimen: Transport at room temperature; refrigerate when storing. | ||||
Unacceptable Conditions: | Blood spot specimen: Blood exhibiting layering, clotting, insufficient quantity, dilution, contamination, serum separation, or didn't soak through the filter paper. For questions call the Newborn Screening Laboratory at 515/725-1630. Blood specimen: Heparin anticoagulant. | ||||
Expected Results: | CFTR Gene: Negative, Cystic Fibrosis mutation, Not Tested. Initial Risk and Final Risk. | ||||
Shipping Instructions | |||||
Blood spot specimen: Place dry blood spot specimen and a completed Cystic Fibrosis Test Request Form in an envelope. Blood specimen: Wrap specimen in absorbent material and place inside a biohazard bag along with a completed Cystic Fibrosis Test Request Form. Transport specimen at room temperature. Send to: Iowa Newborn Screening Program, State Hygienic Laboratory, 2220 S. Ankeny Blvd., Ankeny, IA 50023-9093. | |||||
Comments | |||||
Provided to parents and defined relatives of an infant who has been identified through the Newborn Screening Program to have a Cystic Fibrosis mutation. A negative screen result does not exclude the possibility of a CF mutation not included in this 23 mutation test panel. |